Parkinson Disease

  • 06-01-2016
  • 02:54
  • Neurology

Parkinson Disease

The main target of antiparkinsonian drugs is to increase the dopamine concentration and activity in the brain. Levodopa is transformed into dopamine in the brain, DDC and COMT inhibitors decrease the peripheral metabolism of levodopa. Dopamine agonists a

No Comments